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Abstract
The Staphylococcus aureus HrtAB system is a hemin-regulated ABC transporter composed of an ATPase (HrtA) and a
permease (HrtB) that protect S. aureus against hemin toxicity. S. aureus strains lacking hrtA exhibit liver-specific hyper-
virulence and upon hemin exposure over-express and secrete immunomodulatory factors that interfere with neutrophil
recruitment to the site of infection. It has been proposed that heme accumulation in strains lacking hrtAB is the signal which
triggers S. aureus to elaborate this anti-neutrophil response. However, we report here that S. aureus strains expressing
catalytically inactive HrtA do not elaborate the same secreted protein profile. This result indicates that the physical absence
of HrtA is responsible for the increased expression of immunomodulatory factors, whereas deficiencies in the ATPase
activity of HrtA do not contribute to this process. Furthermore, HrtB expression in strains lacking hrtA decreases membrane
integrity consistent with dysregulated permease function. Based on these findings, we propose a model whereby hemin-
mediated over-expression of HrtB in the absence of HrtA damages the staphylococcal membrane through pore formation.
In turn, S. aureus senses this membrane damage, triggering the increased expression of immunomodulatory factors. In
support of this model, wildtype S. aureus treated with anti-staphylococcal channel-forming peptides produce a secreted
protein profile that mimics the effect of treating DhrtA with hemin. These results suggest that S. aureus senses membrane
damage and elaborates a gene expression program that protects the organism from the innate immune response of the
host.
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Introduction
Staphylococcus aureus is a Gram-positive commensal bacterium
that colonizes the skin and anterior nares of approximately 25 %
of the population [1]. Upon breaching these initial sites of
colonization, S. aureus is capable of causing a range of infections
[2]. Staphylococcal infections affect almost every organ in the
human body ranging from minor skin and soft tissue infections to
more serious diseases such as endocarditis, septicemia, pneumonia
and toxic shock syndrome [3,4]. In order to cause such a diverse
array of pathologies, S. aureus employs an arsenal of virulence
factors including proteins that contribute to immune evasion and
alter immune system function [5].
During infection, S. aureus faces several barriers that interfere with
its ability to replicate and colonize its host. One of these barriers is the
paucity of free iron, which is a critical component of several reactions
within the bacterial cell [6]. To circumvent this barrier, S. aureus can
satisfy its iron needs through acquisition of the metalloporphyrin
heme, whichisa cofactor ofhost hemoglobinandmyoglobin. S.aureus
binds, transports, and releases heme into the cytoplasm through the
combined action of the iron regulated surface determinant (Isd)
system and the heme transport system (Hts) [7,8,9,10,11]. Although
heme is a valuable nutrient iron source at low concentrations, high
concentrations of heme are toxic and therefore heme acquisition
necessitates the presence of heme detoxification systems. In this
regard, S. aureus senses heme exposure through the HssRS two-
component system [12,13] resulting in the up-regulation of the heme
regulated transporter (HrtAB). HrtAB is an ABC-type transporter
that consists of an ATPase (HrtA) and a permease (HrtB) which work
together to alleviate heme toxicity and protect the cell from the
adverse effects of heme accumulation [13,14].
ABC transporters represent one of the largest protein super-
families in both eukaryotes and bacteria [15]. They play a pivotal
role in the transport of a diverse group of molecules across the lipid
bilayer of the cell membrane either to import nutrients or to
export waste and toxic products [16]. ABC transporters consist of
four domains; two transmembrane domains (TMD) and two
nucleotide binding domains (NBD) that couple ATP hydrolysis to
the transport of solutes across the membrane [17,18]. The
subcellular location of ABC transporters within the cell membrane
makes it possible that alterations of ABC transporter structure or
function induce membrane stress.
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virulence in an animal model of infection suggesting that heme
toxicity is linked to staphylococcal virulence. Consistent with this
supposition, hemin-exposed DhrtA exhibits increased expression
and secretion of several immunomodulatory proteins that are
modeled to interfere with immune cell migration to the site of
infection. Taken together, these findings have led to a model
whereby S. aureus strains unable to alleviate heme toxicity through
HrtAB activate an immunomodulatory program resulting in
decreased killing by immune cells and increased virulence [13].
In this manuscript, we propose an alternative model to explain
the hypervirulence of DhrtA. We report that the stimulus which
leads to the increased expression of immunomodulatory proteins
in hemin-exposed DhrtA is membrane damage caused by permease
over-expression rather than intracellular hemin accumulation.
Consistent with this, we present a series of data suggesting that
permease expression in the absence of a cognate ATPase produces
dysregulated pores in the membrane. This membrane damage is
somehow sensed by S. aureus leading to increased expression and
secretion of immunomodulatory factors. This model is further
supported by the observation that exposing wildtype S. aureus to
the channel forming antimicrobial peptide (AMP) gramicidin
results in a secreted protein profile that mimics that of DhrtA
exposed to hemin. The pathological relevance of this response is
demonstrated by results reported here which show that up-
regulation of secreted proteins is responsible for the hyperviurlence
of strains lacking hrtA. Taken together, these data suggest a model
whereby S. aureus senses pore-formation in the cell membrane to
elicit an immunomodulatory program that interferes with
neutrophil recruitment to the site of infection.
Results
S. aureus DhrtA increases expression of
immunomodulatory proteins
In an effort to elucidate the mechanism responsible for the
hypervirulence of S. aureus DhrtA, we analyzed the secreted protein
profiles of staphylococcal strains with mutations in the Hss and Hrt
systems. Upon exposure of DhrtA to hemin in concentrations of
either 0.5 or 2 mM, up-regulation of the production and secretion
of at least five proteins was observed (Fig. 1A). These proteins have
been previously identified through mass spectrometry to be
immunomodulatory proteins that interfere with neutrophil
recruitment to the site of infection [13,19,20,21]. This finding
suggests that strains unable to alleviate hemin toxicity through
Author Summary
Staphylococcus aureus infects almost every tissue within
the human body utilizing a range of virulence factors to
combat host defenses. The expression of these virulence
factors is a tightly regulated process; however, the signals
sensed by S. aureus during infection remain elusive. It has
been hypothesized that heme toxicity is a signal sensed by
S. aureus during infection. This hypothesis is based on the
observation that S. aureus mutants which are incapable of
relieving heme-toxicity due to inactivation of the ATPase
HrtA elicit an immunomodulatory program that interferes
with neutrophil recruitment to the site of infection. In
keeping with this, S. aureus hrtA mutants exhibit liver-
specific hypervirulence. Herein, we provide evidence for an
alternative model to explain the hypervirulent phenotype
of S. aureus DhrtA. We demonstrate that instead of
accumulation of heme toxicity being the trigger for the
observed immunomodulatory program, dysregulated pore
formation caused by the HrtB permease triggers the anti-
neutrophil response. In support of this model, over-
expression of HrtB in wildtype S. aureus or exposing S.
aureus to channel-forming antimicrobial peptides induces
a similar immunomodulatory program. Our work provides
evidence that S. aureus senses membrane damage and
induces an immunomodulatory circuit that helps the
pathogen evade immune-mediated clearance.
Figure 1. Up-regulation of immunomodulatory proteins is
caused by loss of expression of HrtA. (A) Bacterial strains were
grown in (0, 0.5 and 2 mM) hemin in RPMI/CAS for 18 hours and proteins
in culture supernatants were precipitated using 10% TCA, separated
using 15% SDS-PAGE, and stained with Coomassie blue. (B) Exoprotein
profiles of wildtype transformed with control plasmid pOS1 and DhrtA
transformed with control plasmid or plasmids expressing WT HrtA,
catalytically inactive HrtA variants (K45A, G145A, G145T, and E167Q) or
partially catalytically active HrtA (R76A) [14]. All strains were grown in
the presence of 1 mM hemin. Proteins up-regulated under the indicated
condition that have been identified previously using mass spectrometry
are marked with a #. The predicted identities of the proteins in these
bands are as follows; #1 (Exotoxin 8, SACOL0472), #2 (Exotoxin,
SACOL0478), #3 (Exotoxin 3 and 5, SACOL0468/0473), #4 (Efb,
SACOL1168), and #5 (FLIPr, SACOL1166). Positions of protein molecular
mass markers in kilodaltons (kDa) are indicated on the left side of panels
A and B. (C) Immunoblot analysis of protoplast lysates of strains
analyzed in (B). Proteins were resolved using 15% SDS-PAGE, transferred
to nitrocellulose membrane, probed with 9E10 anti-C-Myc monoclonal
primary and AlexaFluor-680-conjugated anti-mouse secondary antibod-
ies. Membranes were then dried and scanned using an Odyssey Infrared
Imaging System.
doi:10.1371/journal.ppat.1000802.g001
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However, a hemin-dependent increase in protein expression was
not observed in either wildtype S. aureus or a strain lacking
functional HssRS (DhssR), the regulatory system which controls
hemin-dependent hrtAB expression (Fig. 1A) [12]. In addition, the
secreted protein profile of a hemin-exposed S. aureus strain
containing a transposon insertion that inactivates the permease
HrtB (thrtB) closely resembled that of wildtype and did not show
changes similar to those observed in DhrtA exposed to hemin
(Fig. 1A). These data indicate that hemin-exposed S. aureus DhrtA
increases the secretion of immunomodulatory proteins, but this
immunomodulatory response does not occur upon loss of HrtB.
The presence of a catalytically inactive HrtA prevents the
hemin-dependent immunomodulatory response
One potential explanation for the discrepancy in secreted
protein profiles observed between DhrtA and thrtB is that the DhrtA
strain has accumulated secondary mutations that are responsible
for altering the secretome. This possibility was eliminated by the
demonstration that the secreted protein profile of hemin-exposed
DhrtA can be complemented by providing a full-length copy of hrtA
in trans (Fig. 1B). HrtA is an ATPase which provides the energy
required for hemin-detoxification by its cognate permease HrtB
[13,14]. Based on the phenotype of the DhrtA mutant, we reasoned
that strains producing a catalytically inactive HrtA would
elaborate a similar secreted protein profile upon hemin exposure.
To test this hypothesis, we transformed DhrtA with plasmids
encoding HrtA proteins that are mutated in key residues in the
conserved nucleotide-binding and hydrolysis motifs (K45A,
G145A, G145T, E167Q) or partially catalytically active (R76A)
[14]. Surprisingly, expression of catalytically inactive versions of
HrtA complemented the secreted protein profile of hemin-exposed
DhrtA (Fig. 1B). These strains expressed comparable levels of HrtA,
eliminating expression level as a possible factor in this analysis
(Fig. 1C). These data indicate that it is not the catalytic activity of
the HrtAB system that is required to prevent up-regulation of the
immunomodulatory proteins upon hemin exposure, but instead it
is the physical presence of HrtA that is required to prevent this
phenotype.
The hrtB and the hrtA genes are transcriptionally linked
Based on the genomic organization of the hrtAB locus, it is
expected that hemin exposure should increase HrtB expression in
strains lacking hrtA. One potential explanation for the phenom-
enon described above is that HrtB acts as an unregulated pore in
the absence of HrtA, sending a stress signal to the cell that leads to
the up-regulation of immunomodulatory proteins. This model
assumes that hrtB and hrtA are co-transcribed and over-expressed
when S. aureus is exposed to hemin. To address this, RT-PCR
experiments were performed using two primers that bind to the 39-
end of the hrtB gene and the 59-end of the hrtA gene, respectively
(Fig. 2A). The results of this experiment showed that hrtA and hrtB
are indeed co-transcribed and transcription of the hrt operon
increases upon hemin exposure (Fig. 2B). These results demon-
strate that hrtA and hrtB comprise a heme-regulated bicistronic
operon.
Loss of HrtB alone does not affect protein secretion or
virulence in mice
To further confirm that it is not inactivation of the HrtAB
system that is responsible for the up-regulation of the immuno-
modulatory proteins, we constructed a strain containing a clean
knock-out of hrtB (DhrtB). Upon examining the secreted protein
profile of DhrtB, no notable changes were observed upon hemin
exposure (Fig. 2C). We next sought to determine if the secreted
protein profiles of DhrtA and DhrtB correlate with virulence levels
in a murine model of systemic staphylococcal infection. Consistent
with what has been reported previously, inactivation of hrtA leads
to a significant increase in liver-specific virulence in this model
[13]. However, when mice were infected with DhrtB, no significant
Figure 2. Loss of HrtB alone does not affect protein secretion or virulence in mice. (A) Diagrammatic representation of the hrtAB locus; the
relative positions of the primers used for RT-PCR are indicated by black arrows. (B) Agarose gels showing the results of an RT-PCR experiment
involving the hrtAB locus and the ribosomal 16S RNA as the loading control. Bacteria were grown 61 mM hemin and RT-PCRs were done using DNA
as the template (DNA), RNA with no reverse transcriptase (No RT) and RNA with reverse transcriptase (+RT). (C) Exoprotein profile of DhrtA + 1 mM
hemin and DhrtB 61 mM hemin. The # indicates the positions of proteins up-regulated under the indicated condition and the predicted identity of
these proteins is as described in Figure 1. Positions of protein molecular mass markers in kilodaltons (kDa) are shown on the left side of the gel. (D)
Bacterial multiplication in infected BALB/c mouse livers as measured by tissue homogenization, dilution, and colony formation on agar media 96
hours post infection. The horizontal bars represent the mean of log10CFU, and the boxes cover the range of log10CFU obtained in each group.
* indicates statistically significant differences from DhrtA as determined by Student’s t test with the indicated p values. NS indicates a non-statistically
significant difference. N indicates the number of mice included in each group.
doi:10.1371/journal.ppat.1000802.g002
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wildtype (Fig. 2D). These data link the secreted protein profile of
hemin-exposed DhrtA to increased virulence and suggest that
inactivation of HrtAB activity is not responsible for this
hypervirulence.
Hemin-exposed DhrtA has decreased membrane
integrity
A potential explanation for the results obtained above is that
hemin-exposed DhrtA over-expresses HrtB which localizes to the
membrane as a dysregulated permease and causes membrane
damage. In turn, this membrane damage is sensed by S. aureus
leading to changes in the secreted protein profile. As an initial test
of this hypothesis, both wildtype and DhrtA were grown in 61 mM
hemin and membrane integrity was determined by propidium
iodide (PI) staining. PI is a membrane impermeant cationic stain
that produces strong red fluorescence when bound to nucleic
acids, and hence can be detected using FACS [22]. When wildtype
S. aureus was exposed to hemin there was a small shift in PI staining
indicating minor changes in membrane integrity (Fig. 3A). In
contrast, DhrtA exposed to hemin exhibited a pronounced shift in
PI staining indicative of substantial changes in membrane integrity
(Fig. 3B). Cell death was excluded as a possible cause of the
increased permeability of hemin exposed DhrtA, as hemin exposure
at this concentration did not affect viability of the tested strains
(Fig. 3C). These results indicate that exposure of DhrtA to 1 mM
hemin compromises cell membrane integrity without affecting
cellular viability.
Hemin-independent over-expression of HrtB elicits a
secreted protein profile that mimics that of
hemin-exposed DhrtA
The data presented above are consistent with a model whereby
HrtB expression in the absence of its cognate ATPase is
responsible for increased secretion of immunomodulatory proteins.
This phenotype can be complemented by catalytically inactive
versions of HrtA suggesting that it is not HrtA ATPase activity but
the physical presence of HrtA that prevents alterations in protein
secretion. In keeping with this, it is predicted that discordant
regulation of HrtB and HrtA would lead to a phenotype that
mimics DhrtA exposed to hemin. To test this hypothesis, myc-
tagged HrtB was constitutively expressed in wildtype, DhrtB and
thrtB backgrounds. The three strains expressed comparable levels
of HrtB as assessed by immunoblots using anti-c-Myc monoclonal
antibody (Fig. 3D). Upon comparing the secreted protein profiles
of these three strains in the absence of hemin exposure to matched
Figure 3. Over-expression of HrtB without hemin exposure mimics the effect of exposing DhrtA to hemin. (A and B) FACS analysis of
wildtype (A) and DhrtA (B) cells incubated 61 mM hemin and stained with propidium iodide (PI). The experiment was performed at least three times
and a representative result is presented. (C) Viable counts of serial dilutions of cell suspensions analyzed in (A and B). (D) Immunoblot analysis of
protoplast lysates of strains transformed with either control plasmid pOS1-plgt (2) or plasmid encoding constitutively expressed Myc-tagged HrtB
phrtB-myc (+). Immunoblots were analyzed as described in Figure 1C. (E) Exoprotein profile of the indicated strains were prepared and analyzed as in
Figure 1. The # indicates the positions of proteins up-regulated under the indicated condition and the predicted identity of these proteins is as
described in Figure 1. (F) Immunoblot analysis of cell fractions of WT/phrtB-myc. Equivalent amounts of proteins were loaded from each fraction and
the immunoblot was analyzed as described in Fig. 1C The reactive band in the cell wall fraction is the S. aureus protein A (Spa), which reacts non-
specifically with anti-c-Myc antibody. Positions of protein molecular mass markers in kilodaltons (kDa) are indicated on the left side of panels D andE .
doi:10.1371/journal.ppat.1000802.g003
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abundance that closely resemble those produced by hemin-
exposed DhrtA (Fig. 3E). This result indicates that expressing
disproportional ratios of HrtB:HrtA triggers a response similar to
that obtained when HrtB is expressed in the absence of HrtA. To
confirm that over-expressed HrtB localizes to the cell membrane,
cell fractionation was performed on wildtype cells harboring the
phrtB-myc plasmid grown in the absence of hemin. When
equivalent protein amounts of cellular fractions were immuno-
blotted using monoclonal antibody against c-Myc, a reactive band
with the predicted molecular mass (,37 kDa) was detected
exclusively in the membrane fraction (Fig. 3F). A second band
migrating at approximately 20 kDa was detected in the membrane
fraction, however the identity of this band in unknown at this
point. These observations support a model whereby HrtB
expression in the absence of HrtA acts as an unregulated pore
resulting in the production of membrane stress and the up-
regulation of immunomodulatory proteins.
Membrane pore formation rather than generalized
membrane damage in wildtype S. aureus mimics the
effect of hemin on DhrtA
To test if the secreted protein profile of hemin-exposed DhrtA is
due to non-specific membrane damage, S. aureus was treated with
sub-inhibitory concentrations of the anti-microbial peptide (AMP)
LL37. LL37 elicits antimicrobial activity through membrane
disruption caused by widespread random intercalation into the
bacterial membrane [23]. We chose to use 40 mg/ml LL37 for
these experiments as this concentration slightly inhibited S. aureus
growth but permitted growth to cell densities that were similar to
untreated cultures (data not shown). When the secreted protein
profiles of S. aureus grown in the absence and presence of LL37
were compared to those of DhrtA grown in the absence and
presence of 1 mM hemin, similar effects regarding the secreted
proteins were not observed (Fig. 4A). None of the five bands that
were visibly up-regulated in hemin-exposed DhrtA were up-
Figure 4. Membrane pore formation but not generalized membrane damage mimics the effect of hemin on DhrtA. (A) Exoprotein
profile of DhrtA treated 61 mM hemin and WT 640 mg/ml of the antimicrobial peptide LL37. (B) Exoprotein profile of DhrtA treated 61 mM hemin
and WT 616 mg/ml of the antimicrobial peptide gramicidin. (C) Exoprotein profile of DhrtA treated with 1 mM hemin and different staphylococcal
strains 632 mg/ml gramicidin. (D) Exoprotein profile of wildtype strains USA500 and RN6390 632 mg/ml gramicidin. Samples were prepared and
analyzed as in Figure 1. The # indicates the positions of proteins up-regulated under the indicated condition and the predicted identity of these
proteins is as described in Figure 1. The * indicates the positions of proteins down-regulated under the indicated condition. Positions of protein
molecular mass markers in kilodaltons (kDa) are indicated on the left side of each panel.
doi:10.1371/journal.ppat.1000802.g004
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that were up-regulated in DhrtA exposed to hemin seemed to be
down-regulated when wildtype was exposed to LL37 (Fig. 4A).
This result indicates that membrane damage caused by LL37
treatment does not induce the same response within S. aureus as
over-expression of the HrtB permease without its cognate ATPase.
Therefore, non-specific membrane damage is not responsible for
alterations in the secretome observed upon HrtA and HrtB
dysregulation.
We next sought to test the impact of a pore-forming AMP on
the staphylococcal secretome to more closely mimic the hypoth-
esized membrane damage elicited upon HrtB over-expression. To
this end, wildtype S. aureus was treated with sub-inhibitory
concentrations of the pore-forming AMP gramicidin. The growth
of S. aureus in the presence of 16 mg/ml gramicidin was slightly
inhibited, but the treated cultures were able to reach similar
optical densities to those of untreated cells (data not shown). Upon
comparing the secreted protein profile of wildtype treated with
gramicidin to that of DhrtA treated with hemin a remarkable
conservation in the expression patterns was observed (Fig. 4B).
Notably, all of the five bands that were up-regulated in hemin-
exposed DhrtA were also up-regulated in gramicidin-treated
wildtype, but to varying extents (Fig. 4B). This result supports
the contention that dysregulated pore formation through the
staphylococcal membrane leads to a specific alteration in protein
secretion. Gramicidin exposure induces significant alterations in
protein expression across a panel of S. aureus isolates (UAMS-1,
USA100, USA300, USA500, and RN6390) (Fig. 4C & D).
Notably, a subset of these strains (UAMS-1, USA100, and
USA300) exhibit altered expression of proteins migrating to
positions similar to those of the immunomodulatory proteins
affected in the Newman strain (Fig. 4C). It is interesting to point
out that not all strains analyzed were affected by gramicidin
treatment equally. More specifically, USA500 and RN6390 do not
seem to increase expression of the immunomodulatory proteins
(based on migration pattern) upon gramicidin exposure despite
exhibiting significant changes in protein expression (Fig. 4D).
Taken together, these experiments suggest that treatment of
distinct S. aureus strains with pore forming toxins produces changes
in protein expression.
The S. aureus Aps/Gra system is a two-component system
responsible for resistance to antimicrobial peptides suggesting a
potential involvement in the response to gramicidin reported here
[24,25]. To evaluate the involvement of Aps/Gra in this response
to gramicidin, we created a S. aureus strain inactivated for Aps/Gra
(DapsR) and measured the impact of HrtB over-expression and
gramicidin exposure on this strain. The secreted protein profile of
DapsR did not differ noticeably from that of wildtype (Fig. S1A &
B). These experiments revealed that the Aps/Gra system is not
involved in the response to gramicidin or HrtB overexpression.
The secretome of wildtype S. aureus treated with
gramicidin resembles that of DhrtA exposed to hemin
Gel based comparisons of protein secretion between gramicidin-
treated wildtype and hemin-exposed DhrtA suggest that these
distinct but similar stressors lead to analogous alterations in the
staphylococcal secretome (Figs. 3E and 4B). In an effort to increase
the sensitivity and resolution of this comparison beyond Coomas-
sie blue-stained SDS-PAGE analysis, a mass spectrometry-based
approach known as shotgun proteomics (see Materials and
Methods) was employed. Using shotgun proteomics we deter-
mined the proteomes of the culture supernatants of DhrtA grown in
the presence and absence of hemin and wildtype S. aureus grown in
the presence and absence of gramicidin. The analysis was
performed on three independent samples from each condition.
Quantitation of the proteins in each sample was performed using
spectral counting of tandem spectra acquired for each protein
normalized to the total number of spectra detected in the same
sample. Analysis of the culture supernatants of DhrtA with and
without hemin revealed the presence of at least 137 proteins
exhibiting an average of at least 2 spectra in the three samples
analyzed. Among these, 21 proteins were significantly up-
regulated and 50 proteins were down-regulated in the presence
of hemin (Table S2). Analysis of known secreted proteins
demonstrated that there were 12 proteins significantly up-
regulated and 18 proteins significantly down-regulated between
these conditions (Tables 1 & 2, Figs. 5A & B). In the case of
wildtype grown in the presence and absence of gramicidin, 101
proteins were detected among which 32 proteins were significantly
up-regulated and 29 were down-regulated (Table S3). Among the
12 secreted proteins that were up-regulated in DhrtA exposed to
hemin, 8 proteins (i.e. 75%) were also up-regulated in WT exposed
to gramicidin (Table 1 and Fig. 5A). All 8 of these proteins have
potential immunomodulatory functions including seven Staphylo-
coccal Superantigen-Like proteins (Ssl1, Ssl2, Ssl4, Ssl5, Ssl6, Ssl7,
and Ssl10) and the extracellular matrix and plasma binding
protein (Ssp, also known as Emp). In addition three other Ssls
(Ssl9, Ssl8 and Ssl3) were up-regulated under both conditions but
their up-regulation did not reach the level of significance in
wildtype treated with gramicidin (Table 1).
Among the 18 secreted proteins that were down-regulated in
DhrtA exposed to hemin, 16 proteins (i.e. 89%) were also
significantly down-regulated in wildtype treated with gramicidin
(Table 2 and Fig. 5B). This group of proteins included several
hemolysins, leukotoxins, and other known virulence factors. Two
additional proteins (SspB and CHIPS) that were significantly
down-regulated in DhrtA exposed to hemin were also down-
regulated in wildtype exposed to gramicidin but their down-
regulation did not reach the level of significance (Table 2). Taken
together, these results demonstrate that pore formation through
gramicidin treatment or permease dysregulation results in
alterations in the staphylococcal exoprotein profile highlighted
by an increased abundance of immunomodulatory proteins with
known anti-neutrophil functions [19,26,27].
Alterations in protein secretion upon pore formation
occur at the transcriptional level
In order to determine whether the changes observed in the
secretomes of DhrtA treated with hemin and wildtype treated with
gramicidin are occurring at the transcriptional level, quantitative
real-time RT-PCR was performed on a representative sample of
genes. Upon testing the transcript levels of ssl7, ssl1, and ssl2 as
examples of genes encoding proteins that increase abundance
upon pore formation, we noted a significant up-regulation in the
level of all three transcripts in both DhrtA treated with hemin and
wildtype treated with gramicidin (Figs. 5C & D). The fold up-
regulation in DhrtA treated with hemin was higher than that
observed in wildtype exposed to gramicidin. Further, upon testing
the transcript levels of lukS, hlgC, and hlgA as examples of genes
encoding proteins that decrease abundance upon pore formation,
there was a significant down-regulation in the level of all three
transcripts in DhrtA treated with hemin. This down-regulation was
only significant in lukS and hlgC in wildtype treated with gramicidin
(Figs. 5E & F). These findings demonstrate that the alterations in
protein abundance that occur upon HrtB dysregulation or
gramicidin treatment are occurring transcriptionally, consistent
with the notion that S. aureus regulates an anti-neutrophil response
upon sensing membrane damage elicited by pore forming toxins.
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Protein DhrtA - hemin DhrtA + hemin p-value











Ssl7 105 15 366 34 0.0003 101 6 310 17 0.0000
Ssl1 20 2 219 21 0.0001 43 3 110 13 0.0009
Ssl2 15 1 56 16 0.0124 20 3 43 8 0.0088
Ssl4 13 4 78 19 0.0039 22 2 49 6 0.0022
Ssl6 4 0 59 12 0.0014 7 3 20 3 0.0066
Ssl5 2 3 29 7 0.0038 6 1 19 2 0.0011
Ssl10 12 1 42 12 0.0127 16 1 20 1 0.0146
Ssp 79 3 217 23 0.0005 96 5 108 2 0.0228
Ssl8 8 1 34 9 0.0090 10 1 20 7 0.0660
Ssl3 7 2 30 5 0.0026 12 1 14 2 0.2429
*
Ssl9 6 1 53 15 0.0056 11 2 12 2 0.8676
*
FnbA 2 1 7 1 0.0019 3 1 1 1 0.0477
¥
1Mean of the number of spectra detected in the three samples analyzed for this condition.
2Standard deviation among the number of the spectra detected in the three samples analyzed for this condition.
3p-value as obtained by applying Student’s t-test.
*The up-regulation of these proteins in the presence of gramicidin was not statistically significant.
¥This protein was significantly down-regulated in the presence of gramicidin.
doi:10.1371/journal.ppat.1000802.t001
Table 2. Secreted proteins down-regulated in (DhrtA + hemin) and (WT + gramicidin).
Protein DhrtA - hemin DhrtA + hemin p-value











LukS 212 14 87 2 0.0001 243 21 103 12 0.0005
HlgC 141 4 46 19 0.0011 120 5 62 8 0.0004
HlgA 132 6 78 18 0.0076 104 6 62 9 0.0028
LukF 100 14 33 3 0.0013 132 4 45 4 0.0000
Truncated MAP 80 16 19 6 0.0035 53 3 14 0 0.0000
Autolysin 58 4 15 1 0.0000 88 8 61 4 0.0057
LukD 56 4 17 5 0.0005 82 3 30 2 0.0000
LukE 53 3 21 4 0.0003 68 4 35 10 0.0060
Hla 46 4 28 5 0.0091 41 3 3 3 0.0001
Truncated lipase 45 4 36 2 0.0280 54 9 33 6 0.0265
Sbi 38 4 24 5 0.0237 52 1 23 2 0.0000
Coa 26 4 8 2 0.0028 29 5 19 2 0.0343
Lip 25 1 13 1 0.0004 36 4 26 1 0.0159
SsaA-like 12 2 5 1 0.0080 15 2 8 1 0.0151
NAMLA amidase
y¥ 18 5 4 1 0.0126 8 2 1 1 0.0105
59-nucleotidase
¥ 150 14 93 2 0.0024 148 13 119 11 0.0395
SspB 8 1 1 1 0.0009 6 1 3 2 0.0764
*
CHIPS 169 20 108 9 0.0088 164 11 151 33 0.5285
*
1Mean of the number of spectra detected in the three samples analyzed for this condition.
2Standard deviation among the number of the spectra detected in the three samples analyzed for this condition.
3p-value as obtained by applying Student’s t-test.
*The down-regulation of these proteins in the presence of gramicidin was not statistically significant.
yNAMLA stands for N-acetylmuramoyl-L-alanine amidase domain protein.
¥This protein contains a probable N-terminal signal peptide sequence.
doi:10.1371/journal.ppat.1000802.t002
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increased expression and secretion of Ssl1-11 and Ssp
Strains lacking hrtA exhibit liver-specific hypervirulence and
increased secretion of immunomodulatory proteins such as Ssls
and Ssp. To determine if the increased secretion of these
immunomodulatory proteins is responsible for the hypervirulence
of hrtA mutants, we created strains lacking ssl1-11 or ssp in a thrtA
background (thrtADssls, thrtADssp, thrtADsslsDssp). Next we assessed
the liver-specific virulence of S. aureus wildtype, thrtA, thrtADssls,
thrtADssp, and thrtADsslsDssp in the systemic model of staphylococ-
cal infection described above. As expected, thrtA exhibited
increased virulence in these studies as compared to wildtype.
Inactivation of either ssl1-11 or ssp reduced the virulence of thrtA to
levels approximately equivalent to wildtype despite the fact that
Figure 5. Treatment of S. aureus wildtype with gramicidin and DhrtA with hemin elicit similar secretomes. (A) Average number of
spectra per protein of secreted proteins that were significantly up-regulated in DhrtA + 1 mM hemin and WT + 32 mg/ml gramicidin. (B) Average
number of spectra per protein of secreted proteins that were significantly down-regulated under both conditions. The data presented are means of
three independent samples and the error bars represent the standard deviation. The differences between DhrtA + hemin (black bars) and DhrtA -
hemin (white bars) and WT + gramicidin (diagonally streaked bars) and WT - gramicidin (grey bars) are statistically significant in all the presented
proteins with p values less than 0.05 as indicated by Student’s t test. * T stands for truncated. (C-F) Results of quantitative real-time RT-PCR using RNA
samples isolated from samples of DhrtA 6 hemin and WT 6 gramicidin. The levels of the transcripts were normalized using the levels of the
ribosomal RNA 16S and the levels of the normalized transcripts from samples without treatment (either hemin or gramicidin) were used as calibrators.
The data presented are the means of two independent experiments with each done in triplicate and the error bars represent the standard deviation.
The differences between DhrtA + hemin (black bars) and DhrtA - hemin (white bars) and WT + gramicidin (diagonally streaked bars) and WT -
gramicidin (grey bars) are statistically significant in all the presented transcripts with p values less than 0.05 as indicated by Student’s t test except the
one data point marked with NS.
doi:10.1371/journal.ppat.1000802.g005
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Inactivation of ssp had a more pronounced effect on the
hypervirulence of thrtA as compared to ssl1-11 underscoring the
significant contribution of Ssp to the hypervirulence of thrtA. When
the mutations of the ssls were combined with that of the ssp in the
hrtA mutant background, the hypervirulence of the hrtA mutant
was significantly reduced almost to the level of wildtype (Fig. 6).
Taken together, these data demonstrate that the hypervirulence of
hrtA mutants is due to the increased expression of Ssl1-11 and Ssp
in response to dysregulated pore formation.
Discussion
S. aureus HrtAB is an ABC-type transport system that is essential
for alleviating hemin toxicity [13,14]. Upon hemin exposure
HrtAB is up-regulated approximately 45-fold [28]. Inactivation of
hrtA results in liver specific hyper-virulence that is associated with a
hemin-induced over expression of immunomodulatory proteins
[13]. Here we propose a revised model to explain the hyper-
virulence of S. aureus DhrtA as summarized in Fig. 7A; when DhrtA
is exposed to hemin, the HssRS system is activated leading to the
over-expression of HrtB in the cell membrane without its cognate
ATPase. In addition to an inability to relieve heme-toxicity [13],
this mutant experiences membrane stress caused by the over-
expressed HrtB permease acting as an unregulated pore. This
membrane stress is sensed by S. aureus through an as-yet-
unidentified mechanism, leading to over-expression and secretion
of several immunomodulatory molecules. The combined action of
these immunomodulatory proteins inhibits neutrophil migration to
the site of infection enabling DhrtA to exhibit hypervirulence
during liver colonization. This model is supported by the
observation that S. aureus exposed to a pore forming AMP exhibits
a similar secreted protein profile to hemin-exposed DhrtA,
potentially providing a physiologically relevant explanation for
the existence of this response (Fig. 7B). When S. aureus senses
membrane damage in the form of pore formation, the organism
appears to over-express and secrete immunomodulatory molecules
that interfere with the recruitment of phagocytic cells to the site of
infection. The observation that strains lacking hssR also exhibit
hypervirulence suggest that disruption of HssRS signaling impacts
HrtAB expression in a way that leads to a similar form of
membrane damage [13].
The precise mechanism by which HrtB over-expression leads to
membrane stress is not completely understood, but lack of
expression of the HrtA protein may lead to misfolding of its
cognate permease (HrtB), or lock the HrtB pore in a conformation
that no longer allows the passage of its substrate, and/or allows the
passage of ions involved in maintaining membrane potential.
These possibilities are in accordance with the observation that
over-expression of membrane proteins usually leads to reduced
growth rates that are generally assumed to be due to negative
effects on membrane integrity [29]. An indication that DhrtA
exposed to hemin experiences membrane damage is provided by
the observation that this strain showed increased permeability to
propidium iodide (Fig. 3B) [22].
During infection, S. aureus faces an array of membrane
damaging peptides and small proteins that perturb the cell
membrane leading to cell leakage and eventually death [30,31].
In fact, mammalian cells increase the production of several AMPs
upon sensing S. aureus and its components [31,32,33]. In general,
AMPs exert their antimicrobial activity through pore formation or
membrane barrier disruption, however some AMPs mediate their
antibacterial activity through altering septum formation or
inhibiting cell-wall, nucleic-acid, or protein synthesis [34,35,36].
Few AMPs have been described that are considered channel-
forming peptides that act through what is known as the ‘‘barrel-
stave’’ mechanism [35,37]. On the other hand, several AMPs,
including the widely expressed human LL37, have been described
to perturb membranes through what is known as the ‘‘carpet’’ or
‘‘detergent like’’ mechanism [23,37].
To counter the bactericidal effects of AMPs, bacteria express
regulatory systems designed to sense these innate immune threats
to generate an anti-AMP response. Among these systems, the
Gram negative PhoPQ system is the best characterized [38].
Recently, the staphylococcal counterpart of the PhoPQ system was
identified [25,39,40]. The Aps/Gra system is a three component
bacterial sensing system that senses AMPs to induce a resistance
response that includes modification of cell surface components and
increased expression of putative AMP transporters [25,39,40].
The Aps/Gra system is not involved in the phenotypes reported
here, implying the existence of an additional system responsible for
sensing membrane damage in S. aureus [40,41,42]. The S. aureus
Figure 6. Ssls1-11 and Ssp are responsible for the liver-specific
hyper-virulence of hrtA mutants. (A) Growth curve analysis of
wildtype, thrtA, thrtADssls, thrtADssp, and thrtADsslsDssp. Overnight
cultures were diluted 1:20 in TSB and the absorbance at 600 nm was
recorded at the indicated time points. A representative growth curve is
presented. (B) Bacterial multiplication in infected BALB/c mice livers as
measured by tissue homogenization, dilution, and colony formation on
agar media 96 hours post infection. The horizontal bars represent the
mean of log10CFU, and the boxes cover the range of log10CFU obtained
in each group. * indicates statistically significant differences from thrtA
as determined by Student’s t test with the indicated p values. NS
indicates a non-statistically significant difference. N indicates the
number of mice included in each group.
doi:10.1371/journal.ppat.1000802.g006
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regulated upon exposure to the pore-forming peptide gramicidin
which is produced by Bacillus brevis. In contrast, this response is not
elicited upon exposure to the membrane-disintegrating mamma-
lian peptide LL37. Considering the apparent specificity of this
secreted protein response to inhibit neutrophil migration, it is
likely that as-yet-unidentified channel-forming AMPs elicit this
response during mammalian infection.
S. aureus regulation of virulence factors in response to phagocytes
and phagocytosis-related signals have been previously reported
and the response varies according to the setting of the experiment
and the strain tested. For instance, the S. aureus virulence regulator
Sae is highly activated upon exposure to a-defensins and H2O2 but
not LL37 [43]. When S. aureus strain SG511 was exposed to
human b-defensin 3, the only pathogenic factors that were
significantly up-regulated were fmtA and sdrE [44]. In a more
comprehensive study [45], different S. aureus strains were
phagocytosed by human PMNs and transcriptome analyses of
these bacteria showed up-regulation of genes encoding multiple
virulence factors such as hlgA, hlgB, hlgC, extracellular matrix and
plasma binding protein (ssp), staphylocoagulase, and clumping
factor. Interestingly, genes encoding several toxins, such as ssl7,
ssl11, ssl10 (set14), lukD, and lukE were up-regulated only in strains
causing community acquired (CA) infections. When the CA-
MRSA strain MW2 was exposed to neutrophil azurophilic granule
proteins [46], there was an up-regulation of genes encoding
numerous virulence factors including hemolysins (hla, hld, hlgA,
hlgB, and hlgC) and leukotoxins (lukS and lukF) in addition to several
immunomodulatory toxins belonging to the Ssl group (ssl7, ssl1
and ssl10). In this manuscript we report that the S. aureus strain
Newman response to either over-expression of the HrtB permease
or the pore-forming AMP gramicidin is different from previous
reports. We have observed up-regulation of the immunomodula-
tory Ssl exoproteins (Ssl7, 1, 2, 4, 6, 5, and 10) and extracellular
matrix and plasma binding protein (Ssp) while simultaneously
observing a down-regulation of several hemolysins, cytotoxins and
other secreted virulence proteins. As observed with S. aureus strain
Newman, we found that UAMS-1, USA100, USA300, USA500
and RN6390 undergo profound changes in protein expression
upon exposure to gramicidin (Fig. 4C and D). A subset of these
strains (UAMS-1, USA100, and USA300) exhibit altered expres-
sion of proteins migrating at the predicted size for the
immunomodulatory proteins affected in the Newman strain. It is
interesting to point out that not all strains analyzed were affected
by gramicidin treatment equally. More specifically, USA500 and
RN6390 do not seem to increase expression of the immunomod-
ulatory proteins upon gramicidin exposure despite exhibiting
significant changes in protein expression (Fig. 4D). From these
data, we conclude that S. aureus alters exoprotein expression in
response to pore-forming toxins.
The Ssl proteins have sequence and structural homology with
superantigens; however they lack the superantigenic activity [19].
Functions have yet to be ascribed to each of the Ssl proteins, but
those with known functions have been shown to have an
immunomodulatory effect. For instance Ssl7 binds IgA and
complement C5, blocking IgA-FcR interactions and complement
activation [26]. Both Ssl5 and Ssl11 inhibit neutrophil rolling
while Ssl5 was recently shown to inhibit leukocyte activation by
chemokines and anaphylatoxins [27,47]. In addition, Ssl10 inhibits
CXCL12-induced human tumor cell migration [48]. However,
very little is known about the regulation of these exotoxins [19]. It
was shown that ssl4 (set9) is up-regulated in a SarA-dependent
manner while ssl3 (set8) is up-regulated in an agr-dependent
manner [49]. Combining these observations with the fact that
many of the virulence factors that are down-regulated in our
experiments such as Hla, HlgABC, Lip, and Map are also
regulated through these two major S. aureus virulence regulators
(agr and SarA) [49], it is tempting to speculate that one or both of
these regulators may play a role in orchestrating the immuno-
modulatory program elicited by membrane damage caused by
pore formation.
In conclusion, the data presented here shed light on a
potentially new virulence regulatory circuit in S. aureus that can
modulate the immune response in the host and the components of
such a circuit represent potential therapeutic targets. The
significance of this circuit stems from the fact that an inducer of
this program, the antimicrobial agent gramicidin, is a component
in preparations that have shown efficacy against S. aureus
Figure 7. Membrane damage triggers immunomodulatory proteins secretion. (A) When DhrtA is exposed to hemin
(1) the HssS/R system is
activated
(2) leading to over-expression of the hrtB gene
(3) causing membrane damage by the over-expressed HrtB proteins acting as unregulated
pores
(4). This in turn activates an internal signal
(5) that turns on the expression
(6) and secretion
(7) of the immunomodulatory proteins. (B) When WT
S. aureus is attacked by antimicrobial peptides
(1) that form pores in the membrane
(2), this in turn activates an internal signal
(3) that turns on the
expression
(4) and secretion
(5) of immunomodulatory proteins.
doi:10.1371/journal.ppat.1000802.g007
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factors involved in transducing the signal from the membrane
which activates the expression and secretion of these immuno-
modulatory factors is critical for the full understanding of this
program and is the focus of future research.
Materials and Methods
Ethics statement
All procedures involving animals were approved by Vanderbilt
University’s Institutional Animal Care and Use Committee
(IACUC). All animal experiments were performed in accordance
to NIH guidelines, the Animal Welfare Act, and US federal law.
Bacterial strains, plasmids and growth conditions
Staphylococcus aureus clinical isolate Newman [52] was used in all
experiments as the wildtype strain (unless explicitly stated) and
mutants were generated in its background. Isogenic mutants
lacking the hrtA and hssR gene were previously described [13]. A
strain containing a transposon insertion into hrtB (thrtB) was
obtained from the Phoenix (N) library clone PhiNE 05560
(SAV2360) [53]. Plasmids expressing WT and mutated hrtA genes
were described previously [14]. S. aureus were grown on tryptic soy
broth (TSB) solidified with 1.5 % agar at 37uC or in TSB with
shaking at 180 rpm, unless otherwise indicated. When appropriate
TSB was supplemented with chloramphenicol at a final concen-
tration of 10 mg/ml. Escherichia coli were grown in Luria broth (LB)
and when needed, the media were supplemented with ampicillin
at a final concentration of 100 mg/ml.
Construction of mutants
Construction of the hrtB deletion mutant strain. The
DhrtB mutant lacking the hrtB gene was constructed using
established methods [54]. Briefly, a PCR amplicon containing
the first 12 bp of the hrtB ORF together with approximately
600 bp upstream of the hrtB ORF was amplified using primers
AA431 (59-GGGGACCACTTTGTACAAGAAAGCTGGGTT-
AACGTCATCGTTTTA-39) and AA407 (59-GCACCTCCA-
ATTGCTTCGATCGCTAATTTCATATCGATTCACTT-39).
Another amplicon containing the last 24 bp of the hrtB ORF
together with approximately 750 bp downstream of the hrtB ORF
was amplified using primers AA404 (59-ATCGAAGCAAT-
TGGAGGTG-39) and AA428 (59-GGGGACAAGTTTGTAC-
AAAAAAGCAGGCTGCCTAAGAACTTAATG-39). The first
amplicon contained in its 39-end 20 bp that are complementary
to the first 20 bp in the 59-end of the second amplicon. Both
amplicons were used together as a template in a second cycle of
PCR using primers AA431 and AA428. The resultant PCR
product was recombined into pKOR1 [54] and used for allelic
replacement into Newman as described [54].
Construction of the ssl deletion mutant strain. The S.
aureus mutant strain lacking ssls 1-11 (Dssl1-11) was constructed
using the pKOR-1 plasmid as described by [54]. Briefly, sequences
flanking the ssl locus were PCR amplified with primers VJT160
(59-GGGGACAAGTTTGTACAAAAAAGCAGGCTAATAGT-
CCTCTTGCTCCTGC-39) and VJT172 (59-TCCCCCCGGG-
TTCAGACACAAAACAGACATC-39) for the upstream frag-
ment and primers VJT124 (59-GGGGACCACTTTGTAC-
AAGAAAGCTGGGTTAAAACCATACCTTCATCATCC- 39)
and VJT173 (59-TCCCCCCGGGGAGTTAATCACTGACT-
TCTAC-39) for a downstream fragment. The PCR amplicons
were cloned into pCR2.1 (Invitrogen), and then digested with
XmaI and assembled into pCR2.1. A PCR amplicon of the joined
DNA fragment was recombined into pKOR1 resulting in the
pKOR-1Dssl1-11plasmid. Deletion of the ssl locus in Newman was
achieved by allelic replacement with pKOR-1Dssl1-11.
Construction of the hrtA::bursa ssl double mutant
strain. An erythromycin cassette insertion mutant of hrtA was
obtained from the Phoenix (N) library (thrtA) [13,53]. The hrtA::erm
mutation was transduced into Newman lacking ssls (Dssl1-11) with
phage W85 [10].
Construction of the ssp deletion mutant strain. Primers
AA547 (59- GGGGACAAGTTTGTACAAAAAAGCAGGCT-
GAAAACACCTGTAGTGTCATTAGA-39) and AA543 (59-
AACCCGGGGCTCATAGTTAAAACTAATAA-39, XmaI site
underlined) were used to amplify the upstream region of the ssp
ORF (NWMN_0758) and primers AA545 (59- CACCCG-
GGGTATAAAAATTGGCACTAAGT-39, XmaI site under-
lined) and AA548 (59- GGGGACCACTTTGTACAA-
GAAAGCTGGGTGGTTTGCTTAATGTGTTAACTTTT-39)
were used to amplify the region downstream of the ssp ORF. Both
PCR amplicons were digested with XmaI then ligated, PCR-
amplified and ligated into pCR2.1 vector. The resulting plasmid
was digested with XmaI and ligated to the non-polar
spectinomycin cassette from plasmid pSL60-1[55]. The PCR
fragment containing the flanking regions and the spectinomycin
resistance cassette was then amplified and recombined into
pKOR1. The Dssp::spc mutant was constructed in strain
Newman as described above then transduced into the thrtA
mutant and thrtA. Dssls mutant background.
Construction of the apsR deletion mutant strain. The
DapsR mutant lacking the apsR gene (NWMN_0628) encoding the
response regulator of the Aps/Gra system was constructed using a
similar approach to that described above for the construction of
the DhrtB and Dssl1-11 mutants.
Construction of a plasmid over-expressing HrtB
For the construction of a plasmid constitutively expressing Myc-
tagged HrtB, a PCR amplicon was made containing the hrtB ORF
into which the sequence encoding a c-Myc-epitope (EQKLI-
SEEDL) was inserted just prior to the stop codon using the primers
DS218 (59- GGGGCATATGAAATTAGCGATAAAAGAG-39,
NdeI site underlined) for the 59-end and AA494 (59- TA-
GATCTTCTTCAGATATCAGTTTCTGTTCGCCGCCTT-
CTGCACCTCCAATTGCTTCGATAGGATCCACTTT-39)
together with AA495 (59-CCTCGAGTTATAGATCTTCTTCA-
GATATCAGTTT-39, XhoI site underlined) for the 39-end. The
PCR product was then digested with both NdeI and XhoI and
ligated into the E. coli/S. aureus shuttle vector pOS1-plgt [56]
which had been digested with the same restriction enzymes.
Ligation mixtures were then transformed into E. coli DH5a and
the resultant plasmid was designated phrtB-myc. After DNA
sequence verification the plasmid was transformed into the
restriction-deficient modification-positive S. aureus RN4220 [57]
followed by transformation into the respective electrocompetent S.
aureus strain using the protocol described [58].
Cell fractionation
S. aureus cells were grown to mid-log phase and sedimented by
centrifugation at 3,2006g for 10 min. The supernatants were
removed and the pellet was suspended in 500 ml TSM (100 mM
Tris-HCl(pH 7.0),500 mMsucrose,10 mMMgCl2)supplemented
with 100 mg lysostaphin and incubated for 1 hr at 37uC. The
resultingprotoplasts weresedimented by centrifugation at 16,0006g
for 15 min; the supernatant was collected [cell wall (CW) fraction],
and the pellet was suspended in 500 ml membrane buffer (50 mM
Tris-HCl (pH 7.0), 10 mM MgCl2, 60 mM KCl) and subjected to
sonication. The membranes were sedimented by centrifugation at
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(Cyt) fraction] and the pellet [membrane (Mem) fraction] was
suspended in 200 ml membrane buffer. Equivalent amounts of
protein from each fraction were separated by SDS-PAGE and
analyzed by immunoblotting as described below.
Measuring membrane integrity using propidium iodide
staining
In order to monitor staphylococcal membrane integrity,
bacterial cells were grown in Roswell Park Memorial Institute
(RPMI) medium supplemented with 1% (wt/vol) Casamino Acids
(CAS) 61 mM hemin until the cultures reached mid-log phase
(OD600 ,0.4), washed and suspended in phosphate buffered saline
(PBS) supplemented with 1% wt/vol bovine serum albumen
(BSA). All samples were adjusted to the same OD600 and 50 ml
aliquots corresponding to approximately 10
7 cells were mixed with
2 mg of propidium iodide (PI) (Sigma) in 1 ml PBS/1%BSA and
analyzed by fluorescence-activated cell sorting (FACS). Analysis
was performed on a FACSCalibur system, (BD, Franklin Lakes,
NJ) using Cell Quest Pro software (BD). Equal aliquots of each
sample were serially diluted and plated on TSA for viability
counting.
Antimicrobial peptides and MIC determination
The AMP LL37 was obtained from Phoenix Pharmaceuticals,
Inc (Burlingame, CA) and it was dissolved directly in RPMI/CAS.
The AMP gramicidin was obtained from Sigma (St. Louis, MO)
and dissolved in absolute ethanol to a final concentration of
10 mg/ml. MIC determination was done by incubating
10
5 CFU/ml S. aureus with 2 fold serial dilutions of the tested
peptide in RPMI/CAS at 37uC. The MIC was considered as the
lowest concentration that prevented growth as indicated by lack of
visible turbidity following incubation at 37uC for 24 hr.
Analyses of secreted proteins
S. aureus cultures from a fresh streak on TSA plates were
inoculated in 5 ml of RPMI/CAS overnight at 37uC. The
overnight cultures were then used to inoculate a new 5 ml culture
in a 15 ml concical tube to which hemin was added at final
concentrations of 0.5, 1, or 2 mM. The AMP LL37 was added to a
final concentration of 40 mg/ml and gramicidin was added to a
final concentration of 16 or 32 mg/ml. As a negative control, cells
were grown in RPMI/CAS with equivalent volume of ethanol
(WT – gramicidin). All the cultures were allowed to grow
overnight (,18 hrs) then the samples were normalized to the
same OD600. Bacterial cells were sedimented by centrifugation
and proteins in the culture supernatants were precipitated using
10% (vol/vol) TCA at 4uC overnight (,16 hrs). The precipitated
proteins were sedimented by centrifugation, washed with absolute
ethanol, dried, resuspended in 1X SDS-loading buffer, and boiled
for 10 min. Proteins in the samples were resolved using 15% wt/
vol SDS-PAGE, and stained with Coomassie blue. At times, we
observed slight variations in protein expression from identical
strains used in distinct experiments as shown in Figures 1, 2, 3, 4,
and S1. This variation correlated with changes in the source of
medium, suggesting that batch-to-batch variation in media
preparations affects this phenotype. Despite these minor varia-
tions, similar patterns of protein expression were observed across
all experiments.
Shotgun proteomics analysis of S. aureus exoproteins
TCA precipitated proteins from filtered culture supernatants of
DhrtA 61 mM hemin and WT 632 mg/ml gramicidin were
prepared as described above. Higher concentration of gramicidin
than what was used above was aimed to increase the sensitivity of
the assay. Proteins were resuspended in 1X SDS-digestion buffer
and loaded into 12% SDS-PAGE gel (without a stacking gel) and
electrophoresed 2 cm into the gel. The gel was stained with
Colloidal Blue (Invitrogen, Carlsbad, CA) then destained with
distilled water over night. Proteins were then subjected to in-gel
trypsin digestion and peptide extraction and the resulting peptides
were then analyzed using a Thermo Finnigan LTQ ion trap
instrument and separated as described [59]. Tandem spectra were
acquired using a data dependent scanning mode with a one full
MS scan (m/z 400–2000) followed by 9 MS-MS scans. The
SEQUEST algorithm was then used to search the tandem spectra
against the Newman strain of the S. aureus subset of the UniRef100
database. To determine false positive rates, the database was
concatenated with the reverse sequences of all proteins in the
database. The SEQUEST outputs were filtered through the ID
Picker suite with a false positive ID threshold of 5% and proteins
were required to be identified by 2 or more unique peptides.
Protein reassembly from identified peptide sequences was done as
previously described [60]. The number of spectra identified for
each protein under a given condition were normalized to the
number of total spectra detected in the same injection.
RNA isolation and manipulation
S. aureus cultures where grown in RPMI/CAS with the
appropriate additive to an OD600 ,1.0. Cultures were then
mixed with equal volume of 1:1 ethanol: acetone mixture and
frozen at -80uC. For RNA extraction, frozen samples were allowed
to thaw on ice; cells were then sedimented and washed two times
with TE buffer. Cells were broken mechanically using fastprep
bead beater (MP Biomedicals, Solon, OH) then RNA was isolated
using the RNeasy mini kit (Qiagen, Valencia, CA) according to the
manufacturer’s recommendation. On-column DNase digestion
was performed and after RNA elution, the samples were cleaned
from any residual DNA contamination using the MessageClean kit
(GenHunter, Nashville, TN).
RT-PCR and real time RT-PCR
RT-PCR was performed to determine if the hrtB and hrtA genes
were transcriptionally linked. 2 mg of RNA isolated as described
above was used as template for a reverse transcriptase reaction
using random hexmer (Promega, Madison, WI) and the M-MLV
reverse transcriptase (Promega). The synthesized cDNA was then
used as a template for a PCR reaction using primers AA492 (59-
TCCTATCGAAGCAATTGGAGGTGC-39) which binds near
the 39-end of the hrtB gene and AA493 (59-TCCCAGAACCA-
GAGGCACCATTTA-39) which binds near the 59-end of the hrtA
gene. Control reactions were carried out where DNA and RNA
without reverse transcriptase treatment were used as templates.
For real time RT-PCR, 50 ng, or 5 ng in case of 16S, of total
RNA was reverse transcribed and PCR-amplified by the Multi-
Scribe enzyme (Applied Biosytems, Foster City, CA) in the
presence of sybr green PCR mix (Applied Biosytems,) using
primers specific for each of the analyzed transcripts (Table S1).
16S RNA was utilized at 5 ng in order to prevent the reaction
rapidly reaching saturation which would hinder normalization.
The levels of all transcripts were normalized to the level of the
ribosomal RNA 16S. The normalized transcript levels of the
respective strain without treatment (either hemin or gramicidin)
were used as calibrators. All samples were analyzed in triplicate
and the data were then analyzed by the iQ5 standard edition
software (Bio-rad, Hercules, CA) using the
DDCT method.
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S. aureus cultures were grown in RPMI/CAS overnight, cells
were then treated with lysostaphin to digest the cell wall and the
resulting protoplasts were pelleted and resuspended in BugBuster
Protein Extraction Reagent (Novagen, Gibbstown, NJ) with
proteinase inhibitor and sonicated for 10 s. Proteins in protoplasts
were then resolved in 15% SDS-PAGE, transferred to nitrocel-
lulose membranes, immunoblotted with 9E10 anti-C-Myc mono-
clonal antibody as a primary antibody and AlexaFluor-680-
conjugated anti-mouse as secondary antibody. Membranes were
then scanned using an Odyssey Infrared Imaging System (LI-Cor
Biosciences, Lincoln, NE).
Murine model of infection
Six- to eight-week-old BALB/c female mice (Jackson Labora-
tories, Bar Harbor, Maine) were infected retro-orbitally with
approximately 1610
7 CFU of S. aureus strains. Ninety-six hours
post-infection, mice were euthanized with CO2, livers were
removed, homogenized in sterile PBS, serially diluted and plated
on TSA for colony forming unit (CFU) counts. At least seven mice
were infected with each strain and statistical analyses were
performed using the Student’s t test, where p values ,0.05 were
considered statistically significant.
Supporting Information
Figure S1 The Aps/Gra system is not involved in the observed
changes in the secreted proteins profile phenotype. (A) Exoprotein
profile of wildtype strain and DapsR containing plasmids pOS1-plg
and phrtB-myc. (B) Exoprotein profile of wildtype strain and DapsR
632 mg/ml gramicidin. The # indicates the positions of proteins
up-regulated under the indicated condition and the predicted
identity of these proteins is as described in Figure 1. Positions of
protein molecular mass markers in kilodaltons (kDa) are indicated
on the left side of each panel.
Found at: doi:10.1371/journal.ppat.1000802.s001 (0.66 MB TIF)
Table S1 Primers used for real time RT-PCR analysis.
Found at: doi:10.1371/journal.ppat.1000802.s002 (0.03 MB XLS)
Table S2 Proteins significantly changed in the culture superna-
tants of (DhrtA + hemin)compared to (DhrtA- hemin).
Found at: doi:10.1371/journal.ppat.1000802.s003 (0.05 MB XLS)
Table S3 Proteins significantly changed in the culture superna-
tants of (WT + gramicidin) compared to (WT - gramicidin).
Found at: doi:10.1371/journal.ppat.1000802.s004 (0.05 MB XLS)
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